CompuGroup Medical SE & Co. KGaA

CMPVFOTCHealthcare

$33.66

+$3.51(+11.64%)

Market Cap$1.7B

P/E Ratio—

52W High$33.66

52W Low$30.15

Avg Volume200

Open$30.15

Beta0.88

Overview

CompuGroup Medical SE & Co. KGaA (CMPVF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CMPVF · free cash flow · updated Jun 8, 2026

Core FCF metrics

CMPVF · FCF · TTM · margin & CAGR

Free cash flow was $125.7M for FY2025 (fiscal year ending 2025-12-31), up 91.5% year-over-year The FCF margin was 10.4%. Five-year CAGR stands at +6.0%.

FY2025 Free Cash Flow$125.7M▲ +91.5% YoY

Trailing 12M (TTM)$114.2Mtrailing 4 quarters sum

FCF Margin10.4%$125.7M ÷ revenue

3-Year CAGR+22.6%FY2022 → FY2025

5-Year CAGR+6.0%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CMPVF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$147.0M(21M)$125.7M▲ +91.5%10.4%

FY2024$128.9M(63M)$65.7M▼ 41.4%5.7%

FY2023$180.1M(69M)$112.0M▲ +64.1%9.4%

FY2022$144.2M(76M)$68.2M▼ 27.4%6.1%

FY2021$165.7M(72M)$94.1M▲ +0.0%9.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CMPVF · P/FCF · FCF yield · FCF per share

CompuGroup Medical SE & Co. KGaA (CMPVF) trades at a FCF yield of 7.53% and a price-to-free-cash-flow ratio of 15.2x. FCF per share stands at $2.21, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

7.53%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$2.21

TTM FCF ÷ Shares Outstanding

Price / FCF

x15.2

Share Price ÷ FCF per Share

EV / FCF (TTM)

x21.3

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CMPVF · cash flow statement · operating / investing / financing

For FY2025, CompuGroup Medical SE & Co. KGaA generated $147.0M in operating cash flow and spent 21M in capital expenditures, yielding $125.7M in free cash flow.

Operating Activities

+$147.0M

Cash from core business operations

2025-12-31

Investing Activities

−$66.2M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$104.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($147.0M) − |CapEx| (21M) = FCF ($125.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CMPVF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CompuGroup Medical SE & Co. KGaAYOU

CMPVF

$125.7M+91.5%10.4%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CompuGroup Medical SE & Co. KGaA (CMPVF) reported free cash flow of $125.7M for FY2025 (fiscal year ending 2025-12-31), up 91.5% year-over-year. The FCF margin was 10.4%.

Based on available data, CompuGroup Medical SE & Co. KGaA has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $125.7M in FY2025. The 5-year CAGR stands at +6.0%.

CompuGroup Medical SE & Co. KGaA's FCF yield is 7.53% and price-to-FCF ratio is 15.2x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CMPVF free cash flow · 8 questions

CompuGroup Medical SE & Co. KGaA free cash flow was $125.7M for FY2025, up 91.5% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $114.2M.

CMPVF free cash flowCMPVF FCFCMPVF FCF 2025CMPVF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CompuGroup Medical SE & Co. KGaA · CompuGroup Medical SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026